Trademark: 97290948
Word
BEKEMV
Status Date
Monday, August 19, 2024
Filing Date
Wednesday, March 2, 2022
Published for Opposition
Tuesday, May 24, 2022
Abandoned Date
Monday, August 19, 2024
5 pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
Apr 14, 2022
Assigned To Examiner
Mar 5, 2022
New Application Entered
Mar 7, 2022
New Application Office Supplied Data Entered
Apr 19, 2022
Approved For Pub - Principal Register
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 18, 2023
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 12, 2022
Sou Teas Extension Received
Dec 12, 2022
Sou Extension 1 Filed
Dec 12, 2022
Sou Extension 1 Granted
Dec 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 8, 2024
Sou Teas Extension Received
Jul 18, 2023
Sou Extension 2 Filed
Jul 18, 2023
Sou Extension 2 Granted
Jul 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 19, 2024
Abandonment - No Use Statement Filed
Aug 19, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 8, 2024
Sou Extension 3 Granted
Jan 8, 2024
Sou Extension 3 Filed
Trademark Alertz updated from USPTO on 2030-01-24